SEC purchase filings

Latest insider buying

Purchase filings through October 27, 2026 · U.S. Eastern Time

These pages include reported purchases (SEC transaction code P), including exchange or private purchases and derivative securities. Stock awards, gifts, exercises, and conversions are different acquisition categories. Filing dates determine these lists; transaction dates are shown separately. Coverage is incomplete.

Reported purchase records

50 loaded records on this page. Ordered by filing date, newest first.

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: NEW GERMANY FUND INCGF · company listingsPurchaseCommon StockNon-derivative security · Code P4,39911.25Value: 49,488.75Currency not specifiedView ↗
Trade: NEW GERMANY FUND INCGF · company listingsPurchaseCommon StockNon-derivative security · Code P9,64311.35Value: 109,448.05Currency not specifiedView ↗
Trade: MEXICO FUND INCMXF · company listingsPurchaseCommon StockNon-derivative security · Code P16,22819.95Value: 323,748.6Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P386,6610.4041 *Value: 156,249.7101Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase ADRsDerivative security · Code P386,661Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P618,6580.4041 *Value: 249,999.6978Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P618,658Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P154,6640.4041 *Value: 62,499.7224Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase ADRsDerivative security · Code P154,664Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P247,4620.4041 *Value: 99,999.3942Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P247,462Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Huh HoyoungDirector · 10% owner
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P3,093,2930.4041 *Value: 1,249,999.7013Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Huh HoyoungDirector · 10% owner
PurchaseWarrants to purchase ADRsDerivative security · Code P3,093,293Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Huh HoyoungDirector · 10% owner
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P618,6580.4041 *Value: 249,999.6978Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Huh HoyoungDirector · 10% owner
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P618,658Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Farag Kameel D.Interim CFO
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P24,7450.4041 *Value: 9,999.4545Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Farag Kameel D.Interim CFO
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P24,745Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Patel Samir RashmikantDirector · 10% owner
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P231,9970.4041 *Value: 93,749.9877Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Patel Samir RashmikantDirector · 10% owner
PurchaseWarrants to purchase ADRsDerivative security · Code P231,997Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Patel Samir RashmikantDirector · 10% owner
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P618,6580.4041 *Value: 249,999.6978Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Patel Samir RashmikantDirector · 10% owner
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P618,658Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P773,3230.4041 *Value: 312,499.8243Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchaseWarrants to purchase ADRsDerivative security · Code P773,323Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P309,3280.4041 *Value: 124,999.4448Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P309,328Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P30,9320.4041 *Value: 12,499.6212Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase ADRsDerivative security · Code P30,932Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P123,7310.4041 *Value: 49,999.6971Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P123,731Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: CALLAN JMB INC.CJMB · company listings
Williams Wayne DCEO, Chairman and President · Director · 10% owner
PurchaseCommon StockNon-derivative security · Code P5,0001.73Value: 8,650Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P36,7011.68Value: 61,657.68Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P20,7951.6787Value: 34,908.5665Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P50,0001.68Value: 84,000Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P36,0221.679Value: 60,480.938Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P50,0001.68Value: 84,000Currency not specifiedView ↗
Trade: Silvia, Inc.SVIA · SVIAW · company listings
Pompliano Anthony John IIIChief Executive Officer · Director · 10% owner
PurchaseCommon Stock, par value $0.001Non-derivative security · Code P298,0003.37Value: 1,004,260Currency not specifiedView ↗
Trade: RENN Fund, Inc.RCG · company listings
STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner
PurchaseCommon StockNon-derivative security · Code P822.65Value: 217.3Currency not specifiedView ↗
Trade: RENN Fund, Inc.RCG · company listings
STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner
PurchaseCommon StockNon-derivative security · Code P182.65Value: 47.7Currency not specifiedView ↗
Trade: RENN Fund, Inc.RCG · company listings
STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner
PurchaseCommon StockNon-derivative security · Code P2962.65Value: 784.4Currency not specifiedView ↗
Trade: RENN Fund, Inc.RCG · company listings
STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner
PurchaseCommon StockNon-derivative security · Code P1802.65Value: 477Currency not specifiedView ↗
Trade: RENN Fund, Inc.RCG · company listings
STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner
PurchaseCommon StockNon-derivative security · Code P1802.65Value: 477Currency not specifiedView ↗
Trade: RENN Fund, Inc.RCG · company listings
STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner
PurchaseCommon StockNon-derivative security · Code P182.65Value: 47.7Currency not specifiedView ↗
Trade: RENN Fund, Inc.RCG · company listings
STAHL MURRAYPresident/Co-Portfolio Manager · 10% owner
PurchaseCommon StockNon-derivative security · Code P3602.65Value: 954Currency not specifiedView ↗
Trade: Texas Pacific Land CorpTPL · company listingsPurchaseCommon StockNon-derivative security · Code P1879.93Value: 879.93Currency not specifiedView ↗
Trade: ELUTIA INC.ELUT · company listings
Makes BrigidDirector
PurchaseClass A Common StockNon-derivative security · Code P25,0000.52 *Value: 13,000Currency not specifiedView ↗
Trade: ELUTIA INC.ELUT · company listings
Mills C RandalPRESIDENT AND CEO · Director
PurchaseClass A Common StockNon-derivative security · Code P3,0000.51Value: 1,530Currency not specifiedView ↗
Trade: GLOBAL PARTNERS LPGLP · company listings
Global GP LLCGeneral Partner
PurchaseCommon units representing limited partner interestsNon-derivative security · Code P2,50042.64 *Value: 106,600Currency not specifiedView ↗
Trade: GLOBAL PARTNERS LPGLP · company listings
Global GP LLCGeneral Partner
PurchaseCommon units representing limited partner interestsNon-derivative security · Code P2,15642.02 *Value: 90,595.12Currency not specifiedView ↗
Trade: GLOBAL PARTNERS LPGLP · company listings
Global GP LLCGeneral Partner
PurchaseCommon units representing limited partner interestsNon-derivative security · Code P1,83642.35 *Value: 77,754.6Currency not specifiedView ↗
Trade: ELUTIA INC.ELUT · company listings
Ferguson MatthewCHIEF FINANCIAL OFFICER
PurchaseClass A Common StockNon-derivative security · Code P60,0000.53 *Value: 31,800Currency not specifiedView ↗

Companies in this loaded sample

How to read an insider purchase filing

Start with the transaction code and security title. Code P identifies a reported purchase on an exchange or in a private transaction. It can involve a derivative security, so a purchase record should not automatically be described as an open-market purchase of common stock. Company listings can include several tickers; the filing identifies the actual security.

What should I compare before using a purchase record?

Check the quantity, price footnotes, currency, and reporting-owner relationships in the original SEC filing. A reference value is quantity × price, not a verified cash settlement. Amounts in a joint filing are not allocated to each named owner. Unknown currencies stay unspecified, and different securities or currencies should not be added into one total.

How complete and current is this list?

These are the records currently loaded from SEC Forms 4, 4/A, 5, and 5/A. Historical collection is incomplete, and these pages do not promise real-time or complete market coverage. The latest view shows at most 50 records per page; use earlier-record links where available. An empty period is not proof that no purchases took place. Sales and net buying/selling totals are not provided.

Read the Form 4 transaction code guide, review common filing questions, or read the SEC investor bulletin. A reported purchase is not a recommendation to invest.